Palantir (PLTR) is riding a violent wave of investor sentiment in 2025. The data intelligence company shattered expectations by posting its first-ever $1 billion quarterly revenue in Q2, fueled by explosive growth across its government and...

A Game-Changing Approval Sparks a Rally August 18, 2025, was a big day for Novo Nordisk (NVO). The FDA just handed Wegovy—its blockbuster weight-loss drug—a major new approval: treatment for metabolic dysfunction-associated steatohepatitis (MASH),...

A Wave of Renewed Optimism for UNH In a move that sent shockwaves through the markets, Warren Buffett’s Berkshire Hathaway revealed today that it scooped up 5 million shares of UnitedHealth Group—a...